Treatment News : Hep B Prevalence in U.S. Is Double the CDC’s Estimate

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » June 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

June 1, 2012

Hep B Prevalence in U.S. Is Double the CDC’s Estimate

The prevalence of chronic hepatitis B virus (HBV) infection in the United States may be as high as 2.2 million cases according to a new study published in Hepatology.

Findings from the study, authored by Kris Kowdley, MD, of Virginia Mason Medical Center in Seattle and his colleagues, suggest the higher prevalence of chronic HBV can be attributed to foreign-born people who were infected in their country of origin before arriving in the states

Emigrants from Asia and Africa, where infection with hepatitis B is highly endemic, represented close to 70 percent of the 1.32 million foreign-born residents living with chronic HBV in the United States in 2009, the authors note.

Chronic HBV is a major health burden that experts say affects up to 400 million individuals worldwide, with up to 25 percent—including many people coinfected with HIV—at risk for premature mortality due to primary liver cancer and end-stage liver disease if the infection is left untreated.

The U.S. Centers for Disease Control and Prevention has estimated that, based on 2006 data, there are between 800,000 and 1.4 million people living with chronic HBV in the country. Kowdley and his colleagues speculated that the true prevalence of chronic HBV is much higher, considering that many people who are at risk for the disease—notably those who are institutionalized, homeless and foreign-born—are typically underrepresented in the national health surveys the CDC uses.

“There is a wide discrepancy in the current estimates of the chronic HBV burden in the U.S.,” Kowdley said in an accompanying news announcement. “Understanding the ethnic and cultural populations affected by chronic hepatitis B will provide more accurate estimates and help to develop programs for prevention, earlier diagnosis and access to care for those at greatest risk.”

To come up with a more accurate U.S. prevalence estimate, the researchers reviewed the world’s medical literature for HBV rates from 1980 to 2010. For the meta-analysis, the team used 256 disease prevalence surveys for emigrants from 52 countries and 1,797 surveys for the general populations of 98 countries. Individuals with lower or higher risk of chronic HBV than the general population and groups not likely to emigrate were excluded. These surveys provided data for populations from the 102 countries of origin for migrants to the United States as determined in the U.S. Census 2009 American Community Survey.

Analysis determined between 1.04 million and 1.61 million (1.32 million estimate) foreign-born residents were living with chronic hepatitis B in the United States in 2009. Chronically infected emigrants were mainly from Asia, Africa and Central America, accounting for 58, 11 and 7 percent of the foreign burden of disease in the United States, respectively.

“Our analysis suggests the total prevalence of chronic HBV is significantly higher, exceeding 2 million cases or twice the number previously reported,” Kowdley said.

In a related editorial also published in Hepatology, John Ward, MD, and Kathy Byrd, PhD, of the CDC’s Division of Hepatitis comment, “The study by Kowdley and colleagues provides evidence that numerous and diverse foreign-born populations in the U.S. are at risk for chronic hepatitis B. Nearly 3.5 percent of all foreign-born persons in the U.S. are living with this disease—a rate more than 10-fold higher than the prevalence of the general U.S. population.”

The editorial’s authors further emphasize the need for culturally specific services along with expanded HBV testing and linkage to care and treatment to prevent new infections, liver disease and cancer.

Search: hepatitis b, hbv, prevalence, estimate, kowdley, cdc, immigrants, emmigrants


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         


[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    aqua_31206
    Macon
    Georgia


    newlife202
    JOLIET
    Illinois


    youngbloodlatino
    Columbia
    Maryland


    robert12
    Queens
    New York
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.